Abstract
Polyunsaturated fatty acid (PUFA) is easily peroxidized by free radicals and enzymes. When this occurs, it results in the compromised integrity of cellular membranes and leads to lipid hydroperoxide as a major reaction product, which is decomposed into aldehyde. Lipid hydroperoxide-modified lysine is known to be an early product of the lipid peroxidation process, suggesting that it might be a PUFA-oxidative stress marker during the initial stage of oxidative stress. Lipid hydroperoxides cause or enhance ROS-mediated DNA fragmentation. The α,β-unsaturated aldehydes are end products of PUFA peroxidation. They are highly reactive and readily attack and modify the protein amino acid residues into aldehyde-modified proteins. Lipid peroxidation-derived α,β-unsaturated aldehydes are capable of inducing cellular stress-responsive processes such as cell signaling and apoptosis. The lipid hydroperoxide- and aldehyde-modified proteins have been immunohistochemically detected in diverse pathological situations such as atherosclerosis, Alzheimer’s disease, Parkinson’s disease, and chemical material-induced liver injury and renal tubular injury in humans and experimental animals. These findings suggest that the expression of the lipid hydroperoxide- and aldehyde-modified proteins is closely associated with the pathogenesis of these diseases in humans and experimental animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aray I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460–464
Bernhard D, Wang XL (2007) Smoking, oxidative stress and cardiovascular diseases-do anti-oxidative therapies fail? Curr Med Chem 14:1703–1712
Bessems JG, Vermeulen NP (2001) Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31:55–138
Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer’s disease. J Neurochem 72:751–756
Castellani RJ, Perry G, Siedlak SL et al (2002) Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett 319:25–28
Castro JA (1984) Mechanistic studies and prevention of free radical cell injury. In: Paton W, Mitchell J, Turner P (eds) Proceedings of IUPHAR 9th International Congress Pharmacol, MacMillan
Cheeseman KH, Albono EF, Tomasi A et al (1985) Biochemical studies on the metabolic activity of halogenated alkanes. Environ Health Perspect 64:85–101
Chen YH, Lin FY, Liu PL et al (2009) Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats. Arch Pharm Res 32:221–228
Chirino YI, Sánchez-González DJ, Martínez-Martínez CM et al (2008) Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245:18–23
Cooper AA, Gitler AD, Cashikar A et al (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 313:324–328
Ekuni D, Tomofuji T, Sanbe T et al (2009) Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis. J Periodontal Res 44:434–442
Fillastre JP, Raguenez-Viotte G (1989) Cisplatin nephrotoxicity. Toxicol Lett 46:163–175
Forni LG, Packer JE, Slater TF et al (1983) Reaction of the trichloromethyl and halothane-derived peroxy radicals with unsaturated fatty acids: a pulse radiolysis study. Chem Biol Interact 45:171–177
Fukuchi Y, Miura Y, Nabeno Y et al (2008) Immunohistochemical detection of oxidative stress biomarkers, dityrosine and Nε-(hexanoyl)lysine, and c-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb 15:185–192
Fukuda M, Kanou F, Shimada N et al (2009) Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer’s disease. Biomed Res 30:227–233
Grant Maxie M, Robinson WF (2007) Cardiovascular system. In: Grant Maxie M (ed) Ubb, Kennedy, and Palmer’s pathology of domestic animals, vol 3, 5th edn. Sanders, New York
Greggi Antunes LM, Darin JDC, Biancii MLP (2000) Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 41:405–411
Hartley DP, Kolaja KL, Reichard J et al (1999) 4-Hydroxynoneal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunohistochemical detection and lobular localization. Toxicol Appl Pharmacol 161:23–33
Higuchi Y (2003) Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol 66:1527–1535
Hinson JA, Roberts DW, James LP (2010) Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 196:369–405
Hisaka S, Kato Y, Kitamoto N et al (2009) Chemical and immunochemical identification of propanoyllysine derived from oxidized n-3 polyunsaturated fatty acid. Free Radic Biol Med 46:1463–1471
Huang A, Sun D, Kaley G et al (1998) Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress-and agonist-induced dilations. Circ Res 83:960–965
Jaeschke H, Bajt ML (2006) Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 89:31–41
Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53:S26–S36
Jomova K, Vondrakova D, Lawson M et al (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345:91–104
Jones TW, Chopra S, Kaufman JS et al (1985) Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations. Lab Invest 52:363–374
Kato Y, Osawa T (2010) Detection of lipid-lysine amide-type adduct as a marker of PUFA oxidation and its applications. Arch Biochem Biophs 501:182–187
Kato Y, Mori Y, Makino Y et al (1999) Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 274:20406–20414
Kawai Y, Kato Y, Fujii H et al (2003) Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein. J Lipid Res 44:1124–1131
Kawai Y, Fujii H, Kato Y et al (2004) Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions. Biochem Biophys Res Commun 313:271–276
Kawai Y, Fujii H, Okada M et al (2006) Formation of Nε-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification. J Lipid Res 47:1386–1398
Kim JS, He L, Lemasters JJ (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463–470
Kristal BS, Park BK, Yu BP (1996) 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 271:6033–6038
Kruidering M, Van de Water B, de Heer E (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complex I to IV of the respiratory chain. J Pharmacol Exp Ther 280:638–649
Larson AM, Polson J, Fontana RJ et al (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364–1372
Lee JY, Je JH, Kim DH et al (2004) Induction of endothelial apoptosis by 4-hydroxyhexenal. Eur J Biochem 271:1339–1347
Liu XY, Yang ZH, Pan XJ et al (2010) Crotonaldehyde induces oxidative stress and caspase-dependent apoptosis in human bronchial epithelial cells. Toxicol Lett 195:90–98
Long EK, Murphy TC, Leiphon LJ et al (2008) Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J Neurochem 105:714–724
Masubuchi Y, Suda C, Horie T (2005) Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 42:110–116
Masuda H, Tanaka T, Takahama U (1994) Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203:1175–1180
McCay PB, Lai EK, Poyer JL et al (1984) Oxygen and carbon-centered free radical formation during carbon tetrachloride metabolism. J Biol Chem 259:2135–2143
Mitra S, Goyal T, Mehta JL (2011) Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drug Ther 25:419–429
Mügge A, Brandes RP, Böger RH et al (1994) Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 24:994–998
Nelson SD (1990) Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 10:267–278
Nicolls MR, Haskins K, Flores SC (2007) Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal 9:879–889
Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007
Recknagel RO, Glende EA Jr, Dolak JK et al (1989) Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 43:139–154
Reynolds ES (1963) Liver parenchymal cell injury. I. Initial alterations of the cell following poisoning with carbon tetrachloride. J Cell Biol 19:139–157
Rumack BH (2004) Acetaminophen misconceptions. Hepatology 40:10–15
Saito C, Yan HM, Artigues A et al (2010) Mechanism of protection by metallothionein against acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 242:182–190
Schmidley JW (1990) Free radicals in central nervous system ischemia. Stroke 21:1086–1090
Shamamoto-Nagai M, Maruyama W, Hashizume Y et al (2007) In Parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J Neural Transm 114:1559–1567
Sugiyama A, Sun J, Nishinohara M et al (2011) Expressions of lipid oxidation markers, Nε-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats. J Vet Med Sci 73:821–826
Sun J, Sugiyama A, Hisaka S et al (2012) Immunohistochemical detection of polyunsaturated fatty acid oxidation markers in acetaminophen-induced liver injury in rats. J Vet Med Sci 74:141–147
Tamer L, Sucu N, Polat G et al (2002) Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch Med Res 33:257–260
Uchida K (1999) Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9:109–113
Uchida K (2000) Role of reactive aldehyde in cardiovascular disease. Free Radic Biol Med 28:1685–1696
Uchida K, Kanematsu M, Sakai K et al (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A 95:4882–4887
Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136
Yao X, Panichpisal K, Kurtzman N et al (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115–124
Yoritaka A, Hattori N, Uchida K et al (1996) Immunohistochemical detection of 4-hydroxynoneal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A 93:2696–2701
Yoshida T, Adachi E, Nigi H et al (1999) Changes of sinusoidal basement membrane collagens in early hepatic fibrosis induced with CCl4 in cynomolgus monkeys. Pathology 31:29–35
Zarkovic K (2003) 4-Hydroxynoneal and neurodegenerative diseases. Mol Aspect Med 24:293–303
Zhou H, Kato A, Yasuda H et al (2004) The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol 200:111–120
Zhou H, Kato A, Miyaji T et al (2006) Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. Nephrol Dial Transplant 21:616–623
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Sugiyama, A., Sun, J. (2014). Immunochemical Detection of Lipid Hydroperoxide- and Aldehyde-Modified Proteins in Diseases. In: Kato, Y. (eds) Lipid Hydroperoxide-Derived Modification of Biomolecules. Subcellular Biochemistry, vol 77. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7920-4_10
Download citation
DOI: https://doi.org/10.1007/978-94-007-7920-4_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7919-8
Online ISBN: 978-94-007-7920-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)